Intravitreal (IVT) Injectables Market is Expected to Rake in Revenues Worth US$ 4,350 Mn by 2028 End

NEW YORK, March 14, 2019 /PRNewswire/ -- Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness. According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions. Anti-VEGF intravitreal (IVT) injectables medication is most likely use to treat retinal disorders. Increasing prescription of anti-VEGF anticipate the growth of the intravitreal (IVT) injectables market. Many manufacturers aims to develop drugs with anti-VEGF inhibitor, as a result leading to an increase in the demand for intravitreal (IVT) injectables.

North America to have substantial revenue growth in intravitreal (IVT) injectables Market

North America region shown to have high growth in intravitreal (IVT) injectables market. Low vision and blindness are prevailing in the region and high prescription of anti-VEGF intravitreal (IVT) injectables medication has increases the growth of intravitreal (IVT) injectables market. It is estimated that intravitreal (IVT) injectables create an incremental $ opportunity worth US$ 4,350 Mn between 2018 and 2028. Lucentis marketed by Roche and Eylea marketed by Regeneron in the United States, are the commonly prescribed biologics use in intravitreal (IVT) injectables. Apart from this, Avastin and Macugen are also widely used in intravitreal (IVT) injectables market. The North America region holds a significant share in intravitreal (IVT) injectables among all other regions, due to the increase in prescription of retinal biologics, high healthcare facilities and availability and usage of expensive drugs.

Get PDF Brochure for Research Insights at: https://www.persistencemarketresearch.com/samples/25906

Intravitreal (IVT) Injectables Market: Segmental Analysis

The global intravitreal (IVT) injectables market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others.

Request a TOC of Report: https://www.persistencemarketresearch.com/methodology/25906

In terms of revenue, the anti-VEGF segment is expected to have a major share in intravitreal (IVT) injectables during the forecast period as it prevents angiogenesis and also minimize the leakage of fluid that occurs due to retinal diseases. On the basis of distributional channel, the intravitreal (IVT) injectables market has been categorized into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. The hospital pharmacies is expected to have high revenue growth in intravitreal (IVT) injectables, owing to the availability of biologics and increase in prescription of anti-VEGF drugs.

Request For Full Report Access: https://www.persistencemarketresearch.com/checkout/25906

Intravitreal (IVT) Injectables Market: Competition Analysis

The report tracks some of the key companies operating in the intravitreal (IVT) injectables market, such as Spark Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., and Bristol-Myers Squibb Company.

Browse Research Release at @ https://www.persistencemarketresearch.com/mediarelease/intravitreal-ivt-injectable-market.asp

The Global Intravitreal (IVT) Injectables Market has been segmented as presented below:

 Global Intravitreal (IVT) Injectables Market, By Geography:

• North America
• Latin America
• Europe
• China
• Japan
• South East Asia & Other APAC
• Middle East & Africa

Browse More:  Life Sciences & Transformational Health Research Reports

Popular Research Reports by PMR:

• Actinic Keratosis Treatment Market- https://www.persistencemarketresearch.com/market-research/actinic-keratosis-treatment-market.asp
• Endodontics And Orthodontics Market- https://www.persistencemarketresearch.com/market-research/endodontics-and-orthodontics-market.asp 
• Hydrogen Breath Test Analyzer Market- https://www.persistencemarketresearch.com/market-research/hydrogen-breath-test-analyzer-market.asp

Persistence Market Research Overview

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Web Site: https://www.persistencemarketresearch.com
Email: [email protected]

SOURCE Persistence Market Research